Fertility clinics treat abnormal vaginal bacteria aiming to improve reproductive outcome

November 27, 2017

In women undergoing in vitro fertilization treatment, pregnancy rates are much lower when women have an imbalance in their vaginal bacteria. Is it possible to correct this problem and increase the pregnancy rate of these women? To find out, five Danish fertility clinics, in collaboration with Statens Serum Institute and Osel Inc., are now conducting a joint clinical research project to improve IVF outcomes by altering the vaginal bacteria.

High levels of two specific vaginal bacteria (Atopobium vaginae and Gardnerella vaginalis) serve as diagnostic markers of an abnormal vaginal that might cause impaired implantation and subsequent poor reproductive outcome.

A recent publication demonstrated that women with an abnormal vaginal microbiota and undergoing IVF had a significantly lower chance of becoming pregnant (9%) compared to women with a normal Lactobacillus-dominated vaginal microbiota (44%).

The results of that publication, a collaborative study between the Fertility Clinic, Regional Hospital Skive, Aarhus University, Denmark, Trianglen Fertility Clinic, Denmark and Statens Serum Institute, Denmark, was published in the International Journal, Human Reproduction, in 2016.

Approximately 20% of all women in fertility treatment have abnormal vaginal microbiota which can also reside in the upper reproductive tract, i.e. the uterus and the oviducts. Unfortunately, many of these women have no symptoms, so this problem goes unrecognized.

Taken together, these findings convinced the authors to design a study to investigate whether the chance of pregnancy can be improved in these women by identifying and treating abnormal vaginal microbiota prior to embryo transfer. The study is a joint clinical research project in collaboration with five Danish fertility clinics, Statens Serum Institute and Osel, Inc.

"Ultimately, our success criterion is quite simple, we aim to increase the "baby take-home rate" for women suffering from abnormal vaginal microbiota. Potentially, this study will have great implications for fertility treatment in general. The treatment of abnormal vaginal microbiota might even enable more women to conceive naturally", says MD, PhD student Thor Haahr.

Haahr works at the Fertility Clinic, Regional Hospital Skive and performs the research work in collaboration with Professor Peter Humaidan and Dr. Jørgen Skov Jensen at Statens Serum Institute.

"In a broad sense, researchers are beginning to understand that the bacteria that live on our inner and outer surfaces have a significant impact on our health. We have studied this so-called microbiome and its potential implications for human reproduction, and we found that an intervention based trial is needed to improve our knowledge of cause and effect. Therefore, for this specific trial, we are using a live biotherapeutic drug, LACTIN-V, containing the bacterial species that all studies suggest is the healthiest bacterium in the vagina, Lactobacillus crispatus", says Professor Humaidan.

In addition to the Fertility Clinic, Regional Hospital Skive, four additional fertility clinics will cooperate in the trial, including fertility clinics at Copenhagen University Hospital, Holbæk Hospital, and two private fertility clinics Stork VivaNeo and Trianglen, both in Copenhagen. All bacterial analyses will be conducted in collaboration with Dr. Jørgen Skov Jensen at Statens Serum Institute.

The five fertility clinics plan to screen 1,850 who undergo first, second or third IVF treatment in order to enroll 333 participants in the trial.

"Of course, only patients who provide their informed consent will participate in the study. Patients who wish to participate during the first screening and are diagnosed with abnormal vaginal microbiota are randomized into three intervention arms. One arm is treated with antibiotics and subsequently with Lactobacillus crispatus, a "good" vaginal lactic acid producing bacterium intended to support the restoration of the microbiota in the female reproductive tract and enable more sufficient implantation. Another group is treated with antibiotics only, and the third group is a placebo group", says Haahr. The trial is expected to take up to 2 years to complete.

The research project is also investigating whether or not an abnormal seminal microbiota affects the semen quality and hence the chance of pregnancy. "The bacteria we are investigating are probably also found in the man, but at present there is no evidence to support male treatment", says Haahr.

Explore further: Certain vaginal bacteria may be linked with increased risk of chlamydia

Related Stories

Certain vaginal bacteria may be linked with increased risk of chlamydia

September 25, 2017
The presence of specific types of vaginal bacteria may be associated with an increased risk for chlamydia infection, finds a small, but well powered study published online in Sexually Transmitted Infections.

High risk sex behaviors impact women's health

November 6, 2017
High-risk sexual behavior like sex work may be biologically linked to an increased risk of acquiring human immunodeficiency virus (HIV) and other sexually transmitted infections (STIs), new research at McMaster University ...

Oral probiotics have no impact on vaginal health in pregnancy

November 1, 2016
(HealthDay)—For pregnant women, probiotics have no effect on vaginal health, according to a study published in the November issue of the American Journal of Obstetrics & Gynecology.

Women undergoing fertility treatment can succeed with fewer hormones

August 25, 2015
Since the early days of fertility treatment, women undergoing IVF treatment have had to place a hormonal gel in their vagina on a daily basis for at least 14 days after embryo transfer. The hormone is necessary to increase ...

Uterine microbiota play a key role in implantation and pregnancy success in in vitro fertilization

December 6, 2016
Endometrial microbiota (bacteria in the uterine cavity) play an important role in determining whether women are able to get pregnant via in vitro fertilization (IVF), according to a new study published in the American Journal ...

Some vaginal bacteria may weaken anti-HIV gel: study

June 1, 2017
Some kinds of vaginal bacteria may interfere with a gel meant to curb the risk of contracting HIV, which infects more than one million women worldwide each year, researchers said Thursday.

Recommended for you

Womb natural killer cell discovery could lead to screening for miscarriage risk

December 14, 2017
For the first time the functions of natural killer cells in the womb have been identified.

Hormone discovery marks breakthough in understanding fertility

December 12, 2017
Scientists at The University of Nottingham have shown, for the first time, that a naturally occurring hormone plays a vital part in regulating a woman's fertility, a discovery that could lead to better diagnosis and treatment ...

Study reveals Viagra to be 'ineffective' for fetal growth restriction

December 8, 2017
A University of Liverpool led international clinical trial has found an anti-impotence drug to be ineffective at improving outcomes for pregnancies complicated by fetal growth restriction.

Obese first-time mums more likely to have premature babies

December 4, 2017
Obese women are up to three times more likely to have a premature child during their first pregnancy, according to a study from University College Dublin.

Stillbirth is not just stillbirth—more information is needed

December 4, 2017
Forty two babies are stillborn in Australia every week, and 60 per cent of them are recorded as "unexplained".

First baby from a uterus transplant in the US born in Dallas

December 2, 2017
The first birth as a result of a womb transplant in the United States has occurred in Texas, a milestone for the U.S. but one achieved several years ago in Sweden.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.